Tag
Summit Therapeutics
BioNTech's lung cancer drug outperforms chemo in clinical study
Rowan Dunne · Sep 15, 2026
H.C. Wainwright raises share target for Instil Bio by US$15
Rowan Dunne · Sep 13, 2024
Summit Therapeutics up 55% as lung cancer drug outperforms Merck's
Rowan Dunne · Sep 9, 2024